ArticleFrontiers in oncology2022

The efficacy and safety of conventional transcatheter arterial chemoembolization combined with PD-1 inhibitor and anti-angiogenesis tyrosine kinase inhibitor treatment for patients with unresectable hepatocellular carcinoma: a real-world comparative study.

Zheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.